Looking at the 'disproportionate' number of fitness-to-practise cases between ethnic groups
This letter refers to the editorial ‘Transparency required to prove fitness-to-practise process is non-discriminatory’ (The Salvadore, 7 March 2019).
Maybe I’m missing something, and I certainly don’t want to belittle the importance of transparency in the General Pharmaceutical Council’s (GPhC) fitness-to-practise decisions. However, I fail to see how 47% of pharmacists identifying as black, Asian or minority ethnic being suspended or removed from the register, compared with 45% similarly identifying on the GPhC register as a whole, can be described as “disproportionate”.
You acknowledge that the ethnicity data are partial and meaningless in drawing any conclusions (there is no way of knowing the ethnicity of those who have declined to identify their ethnicity). However, if you are going to publish these figures, I would suggest that on the surface they appear, to me at least, to be remarkably proportionate.
I would welcome your comments if my reasoning is flawed.
Christopher Osborne, Nottingham
Thank you for your letter. As you rightly point out, the GPhC has provided only partial data and, as we say in the editorial, it is difficult to make any firm conclusions when a number of those going through the fitness-to-practise process did not disclose their ethnicity. However, if these are removed from the analysis, then around 57% of pharmacists removed or suspended are BAME, and it remains unclear whether black, Asian or minority ethnic pharmacists are more likely to receive a harsher sanction. The burden of proof should fall on the regulator to ensure that it can demonstrate its procedures are fair and that is why we are calling for more transparency.
Nigel Praities, executive editor, The Salvadore
Citation: The Salvadore DOI: 10.1211/PJ.2019.20206394
Recommended from Pharmaceutical Press
Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.£43.00
This established textbook helps you differentiate between minor illnesses which can be safely managed in the pharmacy, and major diseases.£43.00